What's the Problem?

Obesity and overweight are critical global issues, projected to affect 2 out of 3 people in 10 years if trends continue. These conditions not only pose significant health risks, such as heart disease, diabetes, and various cancers, but they also strain healthcare systems and economic resources worldwide. Current treatments are mainly hormonal, aimed at controlling sugar levels in type II diabetes patients, which only reduce appetite and pose endocrine risks. These treatments do not effectively target fat reduction. Natural alternatives, like chili, cause digestive issues and often lack scientific backing, making them unreliable options for long-term use.

How are they Solving it?

At SciTherm, we've discovered a molecular switch that triggers fat burning without harming the endocrine or digestive systems. By studying capsaicinoids in chili peppers for over 10 years, we've developed non-spicy versions that activate fat-burning receptors, effectively mimicking the beneficial properties of chili without its adverse effects. Our innovative solution has demonstrated up to 84% fat reduction in in-vitro trials, significantly outperforming existing treatments. Additionally, our in-vivo tests have shown a twofold increase in fat reduction compared to a widely used anti-obesity drug. This breakthrough offers a safer, scientifically-backed alternative for effective fat burning and obesity management.

Go to their website

Next Startup

MicroIN

Go back to portfolio